Neutropenia as a prognostic factor in metastatic colorectal cancer patients undergoing chemotherapy with first-line FOLFOX

被引：0
|
作者：
Shitara, K. [1 ]
Matsuo, K. [1 ]
Takahari, D. [1 ]
Yokota, T. [1 ]
Ura, T. [1 ]
Muro, K. [1 ]
机构：
[1] Aichi Canc Ctr, Nagoya, Aichi 464, Japan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2009年 / 27卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4115
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Retrospective analysis on the efficacy of bevacizumab with FOLFOX as a first-line treatment in Japanese patients with metastatic colorectal cancer
    Suenaga, Mitsukuni
    Mizunuma, Nobuyuki
    Matsusaka, Satoshi
    Shinozaki, Eiji
    Ueno, Masashi
    Yamaguchi, Toshiharu
    ASIA-PACIFIC JOURNAL OF CLINICAL ONCOLOGY, 2014, 10 (04) : 322 - 329
  • [22] Albumin-myosteatosis gauge as a prognostic factor in patients with advanced pancreatic cancer undergoing first-line chemotherapy
    Sahin, Taha Koray
    Ozbay, Yakup
    Altunbulak, Ahmet Yasir
    Altunbulak, Halil Ibrahim
    Onur, Mehmet Ruhi
    Ceylan, Furkan
    Guven, Deniz Can
    Yalcin, Suayib
    Dizdar, Omer
    INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY, 2024, 29 (06) : 822 - 831
  • [23] Prognostic value of chemotherapy-induced neutropenia in advanced gastric cancer patients undergoing first-line chemotherapy with DCF: a retrospective study.
    Wang, Yanrong
    Chen, Yang
    Shi, Yan
    Mao, Hui
    Dai, Guanghai
    BIOMEDICAL RESEARCH-INDIA, 2017, 28 (05): : 2143 - 2151
  • [24] Pharmacogenetic profiling in patients with advanced colorectal cancer treated with first-line FOLFOX-4 chemotherapy
    Ruzzo, Annamaria
    Graziano, Francesco
    Loupakis, Fotios
    Rulli, Eliana
    Canestrari, Emanuele
    Santini, Daniele
    Catalano, Vincenzo
    Ficarelli, Rita
    Maltese, Paolo
    Bisonni, Renato
    Masi, Gianluca
    Schiavon, Gaia
    Giordani, Paolo
    Giustini, Lucio
    Falcone, Alfredo
    Tonini, Giuseppe
    Silva, Rosarita
    Mattioli, Rodolfo
    Floriani, Irene
    Magnani, Mauro
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (10) : 1247 - 1254
  • [25] Multiple genetic polymorphisms in the prediction of clinical outcome of metastatic colorectal cancer patients treated with first-line FOLFOX-4 chemotherapy
    Huang, Ming-Yii
    Huang, Meng-Lin
    Chen, Ming-Jenn
    Lu, Chien-Yu
    Chen, Chin-Fan
    Tsai, Pei-Chien
    Chuang, Shih-Chang
    Hou, Ming-Feng
    Lin, Shiu-Ru
    Wang, Jaw-Yuan
    PHARMACOGENETICS AND GENOMICS, 2011, 21 (01): : 18 - 25
  • [26] Phase II trial of oxaliplatin as first-line chemotherapy in metastatic colorectal cancer patients
    Bécouarn, Y
    Ychou, M
    Ducreux, M
    Borel, C
    Bertheault-Cvitkovic, F
    Seitz, JF
    Nasca, S
    Nguyen, TD
    Paillot, B
    Raoul, JL
    Duffour, J
    Fandi, A
    Dupont-André, G
    Rougier, P
    JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (08) : 2739 - 2744
  • [27] First-Line Mono-Chemotherapy in Frail Elderly Patients with Metastatic Colorectal Cancer
    Varol, Umut
    Dirican, Ahmet
    Yildiz, Ibrahim
    Oktay, Esin
    Degirmenci, Mustafa
    Alacacioglu, Ahmet
    Barutca, Sabri
    Karabulut, Bulent
    Uslu, Ruchan
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (07) : 3157 - 3161
  • [28] Elderly patients with metastatic colorectal cancer: overall issues and first-line chemotherapy options
    Benavides, Manuel
    Berciano-Guerrero, Miguel
    COLORECTAL CANCER, 2013, 2 (06) : 559 - 571
  • [29] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Yan Li
    Department of GI Oncology
    Chinese Journal of Cancer Research, 2010, 22 (03) : 181 - 185
  • [30] Capecitabine Maintenance Therapy after First-Line Chemotherapy in Patients with Metastatic Colorectal Cancer
    Li, Yan
    Li, Jing
    Lu, Ming
    Wang, Xi-cheng
    Shen, Lin
    CHINESE JOURNAL OF CANCER RESEARCH, 2010, 22 (03) : 181 - 185
12345